Acp Journal Club
Publication Venue For
Prasugrel reduced ischemic outcomes more than did clopidogrel in patients receiving stents for ACS.
Review: late percutaneous coronary intervention after AMI improves survival more than optimal medical therapy.
Aspirin was cost-effective for primary prevention of cardiovascular events in older women at moderate risk.
Urgent revascularization with PCI was more cost-effective than CABG in medically refractory, high-risk myocardial ischemia.
Rescue angioplasty reduced cardiovascular and cerebrovascular outcomes in acute MI after failed thrombolytic therapy.
Review: evidence supporting reduced death and reinfarction by percutaneous coronary intervention after thrombolysis is inconclusive.
Prophylactic implantable cardioverter-defibrillators increased life expectancy with an acceptable cost-effectiveness ratio.
Invasive strategy within 24 hours of thrombolysis reduced death, nonfatal reinfarction, and ischemia-induced revascularization in STEMI.
High-dose atorvastatin was superior to standard-dose pravastatin for reducing death or major cardiovascular events in acute coronary syndromes.
Review: low-molecular-weight heparin is effective and safe in the acute coronary syndromes.
An early invasive strategy reduced death, myocardial infarction, and hospital readmissions at 2 years in unstable CAD.
Long-term mortality and cardiovascular morbidity increased in some patients with asymptomatic mitral valve prolapse.
An interventional strategy was better than a conservative strategy in unstable angina or non-ST-elevation MI.
Cardiac resynchronization was effective for moderate-to-severe heart failure with intraventricular conduction delay.
International Standard Serial Number (issn)
Electronic International Standard Serial Number (eissn)